Literature DB >> 12580924

Radiotherapy in acromegaly: a protagonists viewpoint.

J A H Wass1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12580924     DOI： 10.1046/j.1365-2265.2003.01706.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  8 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  Acromegaly.

Authors:  Massimo Scacchi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Does acromegaly enhance mortality?

Authors:  John Ayuk; Michael C Sheppard
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 4.  Mortality following pituitary radiotherapy.

Authors:  John Ayuk; Paul M Stewart
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 5.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Management of type 2 diabetes mellitus associated with pituitary gigantism.

Authors:  Omar Ali; Swati Banerjee; Daniel F Kelly; Phillip D K Lee
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 7.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006

8.  Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes A Romijn
Journal:  Biologics       Date:  2008-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.